Trilogy Capital’s ORIX IX Stock Holding History

Trilogy Capital’s Portfolio IX Stock Details IX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-150	Closed	-$2K	–	355
2018 Q3	$2K	Hold	150	–	–	﹤0.01%	502
2018 Q2	$2K	Hold	150	–	–	﹤0.01%	466
2018 Q1	$3K	Buy	+150	New	+$2.71K	﹤0.01%	350

Other funds holding IX

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Renaissance Group Covington, Kentucky $2.39B AUM 27.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

Trilogy Capital's IX Position: Q4 2018 in Review

Trilogy Capital sold out of ORIX (IX) in Q4 2018, closing a stake of 150 shares — an estimated $2K sold.

Trilogy Capital first reported a position in IX in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2018. 155 funds tracked by Wall St. Rank hold IX as of Q4 2018.

Trilogy Capital reported no remaining ORIX position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 150 ORIX shares in Q4 2018, an estimated $2K.
Trilogy Capital first reported a position in ORIX in Q1 2018 and held it in 3 quarters.
Trilogy Capital's ORIX position peaked at $3K in Q1 2018.
155 funds tracked by Wall St. Rank held ORIX as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.